Entering text into the input field will update the search result below

Rockwell Medical rises on Craig-Hallum note, SFP in focus

Sep. 13, 2013 9:47 AM ETRockwell Medical, Inc. (RMTI) StockAMGN, RMTIBy: Colin Lokey, SA News Editor
  • Rockwell Medical (RMTI +12.4%) trades higher in early action.
  • Craig-Hallum has initiated the shares at Buy with a $16 price target (slightly less optimistic than the $25 objective Summer Street slapped on the shares post-CRUISE-2).
  • The firm thinks SFP is set to become the standard of care.
  • Apparently mentioned in the note is RMTI's potential to reduce erythropoiesis stimulating agent usage. This may end up threatening Amgen's (NASDAQ:AMGN) Epogen and Aranesp, although, as SA contributor Paulo Santos notes, the potential hit to Aranesp might be a larger concern because Epogen is "losing patent protection now, so it's going to be pressured anyway."

Recommended For You

More Trending News

About RMTI Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
RMTI--
Rockwell Medical, Inc.